TLR7 agonist 3

CAS No. 1229024-78-5

TLR7 agonist 3( —— )

Catalog No. M35052 CAS No. 1229024-78-5

TLR7 agonist 3 is a Toll-like receptor 7 (TLR7) agonist that has anticancer activity and is used in the study of diseases of the immune system.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 178 Get Quote
5MG 275 Get Quote
10MG 455 Get Quote
25MG 725 Get Quote
50MG 1030 Get Quote
100MG 1341 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TLR7 agonist 3
  • Note
    Research use only, not for human use.
  • Brief Description
    TLR7 agonist 3 is a Toll-like receptor 7 (TLR7) agonist that has anticancer activity and is used in the study of diseases of the immune system.
  • Description
    TLR7 agonist 3 (Compound 2) is a potent agonist of toll-like receptor 7 (TLR7). TLR7 has an important role in immune activation processes and represents an emerging agent discovery target for the development of immunomodulators.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    TLR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1229024-78-5
  • Formula Weight
    312.41
  • Molecular Formula
    C18H24N4O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (320.09 mM; Ultrasonic ) Ethanol : ≥ 50 mg/mL (160.05 mM)
  • SMILES
    OC(C)(C)CN1C(=NC=2C(=NC=3C=CC=CC3C21)N)CCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Urban ?vajger, et al. New antagonists of toll-like receptor 7 discovered through 3D ligand-based virtual screening. Medicinal Chemistry Research. 2015. 24: 362-371.
molnova catalog
related products
  • CPG-52364

    CPG-52364 (CPG52364) is an orally available, small molecule TLR7/8/9 antagonist for the treatment of systemic lupus erythematosus and other autoimmune disorders.

  • CU-CPT-9a

    CU-CPT-9a is a potent TLR8 inhibitor (IC50 : 0.5 nM) that suppresses TLR8-mediated proinflammatory signaling in various cell lines.

  • Imiquimod

    Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist.